FAT10 differentially stabilizes MYPT2 isoforms
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.07.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Seong Eun Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea. Hauptthemen laut MEDLINE: Ubiquitin, Ubiquitins. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Ministry of Education, National Research Foundation of Korea, Pusan National University.
Abstract (Originalsprache)
Myosin phosphatase (MP) is an enzyme complex that regulates muscle contraction and plays important roles in various physiological and pathological conditions. Myosin phosphatase targeting subunit (MYPT) 2, a subunit of MP, interacts with protein phosphatase 1c to regulate its phosphatase activity. MYPT2 exists in various isoforms that differ in the composition of essential motifs that contribute to its function. However, regulatory mechanisms underlying these isoforms are poorly understood. Human leukocyte antigen-F adjacent transcript 10 (FAT10) is a ubiquitin-like modifier that not only targets proteins for proteasomal degradation but also stabilizes its interacting proteins. In this study, we investigated the effect of the interaction between FAT10 and MYPT2 isoform a (the canonical full-length form of MYPT2) or MYPT2 isoform f (the natural truncated form of MYPT2). FAT10 interacted with both MYPT2 isoforms a and f; however, only MYPT2 isoform f was increased by FAT10, whereas MYPT2 isoform a remained unaffected by FAT10. We further confirmed that, in contrast to MYPT2 isoform a, MYPT2 isoform f undergoes rapid degradation via the ubiquitin-proteasome pathway and that FAT10 stabilizes MYPT2 isoform f by inhibiting its ubiquitination. Therefore, our findings suggest that the interaction between FAT10 and MYPT2 isoforms leads to distinct stabilization effects on each isoform, potentially modulating MP activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
- Department of Herbal Prescription, College of Korean Medicine, Daegu Haany University, Gyeongsan, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Pusan National Univer…
- Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Republic of Korea. Electronic address: dhsohn@pusan.ac.kr.
Förderung
- Ministry of Education
- National Research Foundation of Korea
- Pusan National University
Zitieren
APA
Song, S. E., Kim, Y., Jeong, H., Lee, B., Lee, J., Roh, J. S., So, M. W., Lee, S. G., & Sohn, D. H. (2023). FAT10 differentially stabilizes MYPT2 isoforms. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.07.025
Vancouver
Song SE, Kim Y, Jeong H, Lee B, Lee J, Roh JS, et al. FAT10 differentially stabilizes MYPT2 isoforms. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.07.025
BibTeX
@article{Song2023,
author = {Song, Seong Eun and Kim, Yerin and Jeong, Hoim and Lee, Beomgu and Lee, Jihyeon and Roh, Jong Seong and So, Min Wook and Lee, Seung-Geun and Sohn, Dong Hyun},
title = {FAT10 differentially stabilizes MYPT2 isoforms},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.07.025}
}
EUVIMED